Studies in patients with pancreatic cancer have demonstrated that an elevated CEA at diagnosis was associated with a poorer overall survival compared with patients with a normal serum CEA.78 In a study by Hank et al., 93 patients with oligometastatic disease underwent metastasectomy along with resection of the primary tumor. The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.